Spots Global Cancer Trial Database for A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
Official Title: Retrospective, Multicenter, Observational Study to Evaluate Current Treatment Patterns and Outcomes in Japanese Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With First-line Avelumab Maintenance
Study ID: NCT05431777
Conditions
Interventions
Study Description
Brief Summary: The purpose of this clinical trial is to learn about the current treatment patterns, safety, and effects of the study medicine (Avelumab) for the treatment of urothelial carcinoma. This study is seeking Japanese participants who: * have urothelial cancer that has spread * are treated with Avelumab for maintenance We will study the experiences of people receiving avelumab. This helps us learn the current treatment patterns, safety, and effects of avelumab. Participants will take part in this study up to 10 months. During this time, they will have no study visits.
Detailed Description:
Eligibility
Minimum Age: 0 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
National Hospital Organization Nagoya Medical Center, Nagoya, Aichi, Japan
Asahi General Hospital, Asahi, Chiba, Japan
Kurume University Hospital, Kurume, Fukuoka, Japan
Ogaki Municipal Hospital, Ogaki, Gifu, Japan
St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
SHOWA University Fujigaoka Hospital, Yokohama, Kanagawa, Japan
Nara Medical University Hospital, Kashihara, Nara, Japan
Osaka International Cancer Institute, Osaka-shi, Osaka, Japan
Kindai University Hospital, Osakasayama, Osaka, Japan
Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan
Akita University Hospital, Akita, , Japan
National Hospital Organization Kyushu Cancer Center, Fukuoka, , Japan
University Hospital Kyoto Prefectural University of Medicine IEC, Kyoto, , Japan
University Hospital Kyoto Prefectural University of Medicine, Kyoto, , Japan
Kyoto University Hospital, Kyoto, , Japan
Toyama University Hospital, Toyama, , Japan
Contact Details
Name: Medical Responsible
Affiliation: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
